KREBSBIO.NS

Krebs Biochemicals & Industries Limited [KREBSBIO.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

KREBSBIO.NS Stock Summary

Top 10 Correlated ETFs

KREBSBIO.NS


Top 10 Correlated Stocks

KREBSBIO.NS


In the News

KREBSBIO.NS Financial details

Company Rating
Sell
Market Cap
1.55B
Income
-213.98M
Revenue
460.23M
Book val./share
-50.37
Cash/share
0.95
Dividend
-
Dividend %
-
Employees
210
Optionable
No
Shortable
Yes
Earnings
12 Feb 2024
P/E
-8
Forward P/E
-
PEG
1.52
P/S
3.73
P/B
-1.58
P/C
76.21
P/FCF
-
Quick Ratio
0.05
Current Ratio
0.3
Debt / Equity
-1.73
LT Debt / Equity
-1.64
-
-
EPS (TTM)
-9.77
EPS next Y
-
EPS next Q
-
EPS this Y
-44.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.98%
Revenue last 5Y
7.02%
Revenue Q/Q
40.72%
EPS Q/Q
-32.79%
-
-
-
-
SMA20
-2.67%
SMA50
-8.75%
SMA100
8.96%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
22%
ROC
-0.14%
Gross Margin
84%
Oper. Margin
-37%
Profit Margin
-46%
Payout
-
Shs Outstand
21.56M
Shs Float
4.74M
-
-
-
-
Target Price
-
52W Range
50.65-93.95
52W High
-22.15%
52W Low
+44.8%
RSI
44
Rel Volume
0.66
Avg Volume
18K
Volume
11.97K
Perf Week
0.7%
Perf Month
-7.89%
Perf Quarter
4.93%
Perf Half Y
-8.7%
-
-
-
-
Beta
0.496
-
-
Volatility
0.76%, 2.2%
Prev Close
-0.34%
Price
72.4
Change
-2.82%

KREBSBIO.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
22.3314.6219.6824.5524.18
Net income per share
-12.03-17.9-14.45-20.65-11.45
Operating cash flow per share
-2.2-22.23-7.43-7.98-11.46
Free cash flow per share
-5-28.07-20.43-18.89-16.5
Cash per share
10.330.030.550.110.17
Book value per share
-8.59-15.5-21.78-34.83-46.13
Tangible book value per share
-11.02-17.83-23.57-36.16-47.38
Share holders equity per share
-8.59-15.5-21.78-34.83-46.13
Interest debt per share
60.3654.0754.4529.4786.37
Market cap
1.9B1.25B1.69B3.08B1.22B
Enterprise value
2.67B2.07B2.68B3.66B3.05B
P/E ratio
-9.49-4.34-5.95-6.93-4.93
Price to sales ratio
5.125.324.375.832.34
POCF ratio
-51.84-3.5-11.57-17.91-4.93
PFCF ratio
-22.86-2.77-4.21-7.57-3.42
P/B Ratio
-13.3-5.02-3.95-4.11-1.22
PTB ratio
-13.3-5.02-3.95-4.11-1.22
EV to sales
7.198.766.956.925.85
Enterprise value over EBITDA
-28.29-11.43-15.83-11.24-20.12
EV to operating cash flow
-72.83-5.76-18.42-21.29-12.34
EV to free cash flow
-32.12-4.56-6.7-9-8.57
Earnings yield
-0.11-0.23-0.17-0.14-0.2
Free cash flow yield
-0.04-0.36-0.24-0.13-0.29
Debt to equity
-6.59-3.25-2.35-0.77-1.84
Debt to assets
0.660.610.630.311.05
Net debt to EBITDA
-8.15-4.49-5.89-1.78-12.08
Current ratio
0.560.440.440.450.33
Interest coverage
-2.38-4.01-3.62-7.4-7.3
Income quality
0.181.240.510.391
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.0400.020.02
Research and developement to revenue
00000
Intangibles to total assets
0.030.030.020.020.02
Capex to operating cash flow
1.270.261.751.370.44
Capex to revenue
-0.13-0.4-0.66-0.44-0.21
Capex to depreciation
-1.06-2.01-4.98-3.74-1.66
Stock based compensation to revenue
00000
Graham number
48.237984.16127.22109.03
ROIC
-0.13-0.25-0.4-1.48-0.17
Return on tangible assets
-0.14-0.22-0.18-0.24-0.14
Graham Net
-79.51-93.29-98.04-116.14-124.16
Working capital
-238.85M-242.74M-267.75M-425.71M-330.44M
Tangible asset value
-183.19M-287.66M-462.42M-779.64M-1.02B
Net current asset value
-1.26B-1.4B-1.81B-2.29B-2.58B
Invested capital
-6.59-3.25-2.35-0.77-1.84
Average receivables
23.27M23.59M6.67M11.25M12.38M
Average payables
196.11M220.77M217.34M293.42M265.94M
Average inventory
103.46M119.8M157.98M210.82M187.54M
Days sales outstanding
36.216.022.8313.453.68
Days payables outstanding
201.39251.66145.19187.73217.21
Days of inventory on hand
84.11166.31116126.6169.8
Receivables turnover
10.0822.79128.7727.1499.27
Payables turnover
1.811.452.511.941.68
Inventory turnover
4.342.193.152.882.15
ROE
1.41.160.660.590.25
Capex per share
-2.79-5.83-13-10.91-5.04

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q2

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
9.694.225.054.96.92
Net income per share
-1.88-2.58-3.06-2.47-1.66
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
1.9900.1600.95
Book value per share
-40.410-43.830-50.37
Tangible book value per share
-41.690-45.010-51.58
Share holders equity per share
-40.410-43.830-50.37
Interest debt per share
80.75081.19087.83
Market cap
2.42B2.36B1.28B1.53B1.46B
Enterprise value
4.16B03.11B03.34B
P/E ratio
-14.91-10.63-4.62-7.16-10.24
Price to sales ratio
11.5725.9711.1914.449.82
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
-2.780-1.290-1.35
PTB ratio
-2.780-1.290-1.35
EV to sales
19.86027.17022.43
Enterprise value over EBITDA
-255.70-70.270-459.85
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
-0.02-0.02-0.05-0.03-0.02
Free cash flow yield
00000
Debt to equity
-1.990-1.840-1.73
Debt to assets
0.9501.0501.05
Net debt to EBITDA
-106.740-41.330-258.46
Current ratio
0.4500.3300.3
Interest coverage
-4.47-5.18-5.75-3.86-2.15
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.0200.0200.01
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
41.34054.91043.37
ROIC
-0.040-0.050-0.03
Return on tangible assets
-0.020-0.040-0.02
Graham Net
-119.720-117.960-129.29
Working capital
-296.45M0-330.44M0-389.39M
Tangible asset value
-900.6M0-1.02B0-1.11B
Net current asset value
-2.46B0-2.58B0-2.7B
Invested capital
-1.990-1.840-1.73
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
1.1904.1205.82
Days payables outstanding
110.410436.640731.09
Days of inventory on hand
95.40341.350488.45
Receivables turnover
75.6021.82015.46
Payables turnover
0.8200.2100.12
Inventory turnover
0.9400.2600.18
ROE
0.0500.0700.03
Capex per share
00000

KREBSBIO.NS Frequently Asked Questions

What is Krebs Biochemicals & Industries Limited stock symbol ?

Krebs Biochemicals & Industries Limited is a IN stock and trading under the symbol KREBSBIO.NS

What is Krebs Biochemicals & Industries Limited stock quote today ?

Krebs Biochemicals & Industries Limited stock price is $72.4 today.

Is Krebs Biochemicals & Industries Limited stock public?

Yes, Krebs Biochemicals & Industries Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks